Ocak, T. Et Al. 2024. Secukinumab May Be an Effective Treatment Option for Axial Spondyloarthritis and Psoriatic Arthritis Patients with a History of Malignancy: Multicenter Real-Life Experience from Turkey. Journal of Clinical Medicine , vol.13, no.20 .

Ocak, T., YAĞIZ, B., Ocak, B., Yoğurtçu, Ö., BAŞIBÜYÜK, F., Tezcan, D., ... Ermurat, S.(2024). Secukinumab May Be an Effective Treatment Option for Axial Spondyloarthritis and Psoriatic Arthritis Patients with a History of Malignancy: Multicenter Real-Life Experience from Turkey. Journal of Clinical Medicine , vol.13, no.20.

Ocak, Tuğba Et Al. "Secukinumab May Be an Effective Treatment Option for Axial Spondyloarthritis and Psoriatic Arthritis Patients with a History of Malignancy: Multicenter Real-Life Experience from Turkey," Journal of Clinical Medicine , vol.13, no.20, 2024

Ocak, Tuğba Et Al. "Secukinumab May Be an Effective Treatment Option for Axial Spondyloarthritis and Psoriatic Arthritis Patients with a History of Malignancy: Multicenter Real-Life Experience from Turkey." Journal of Clinical Medicine , vol.13, no.20, 2024

Ocak, T. Et Al. (2024) . "Secukinumab May Be an Effective Treatment Option for Axial Spondyloarthritis and Psoriatic Arthritis Patients with a History of Malignancy: Multicenter Real-Life Experience from Turkey." Journal of Clinical Medicine , vol.13, no.20.

@article{article, author={Tuğba Ocak Et Al. }, title={Secukinumab May Be an Effective Treatment Option for Axial Spondyloarthritis and Psoriatic Arthritis Patients with a History of Malignancy: Multicenter Real-Life Experience from Turkey}, journal={Journal of Clinical Medicine}, year=2024}